medigraphic.com
SPANISH

Revista Cubana de Investigaciones Biomédicas

ISSN 1561-3011 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2011, Number 3

<< Back Next >>

Rev Cubana Invest Bioméd 2011; 30 (3)

Demonstration of flagellum ameba Naegleria fowleri as etiological agent of primary amebic meningoencephalitis in Santiago de Cuba

Sierra CL
Full text How to cite this article

Language: Spanish
References: 25
Page: 318-331
PDF size: 223.97 Kb.


Key words:

Primary amoebic meningo-encephalitis (PAME), Naegleria fowleri, cefalo raquideal fluid.

ABSTRACT

During the last years it has been demonstrated that the flagellae-carring ameba Naegleria fowleri is the aethiologic agent of the primary amoebic meningoencephalitis (PAME), in Cuba the suspicion of its presence has been mentioned in a Cefalo Raquideal Fluid (CRF) of an ameba whose locomotion and circumstances suggested that it could be this organism. The present work carries out the analysis in fresh CRF samples and after culture, performing the Flagelation Test of the 64 CRF that presented the characteristics of transparency and negativity to bacterial culture ,needed to suspicion of this flagellae-carring ameba, leaving of an starting sample of 1488 CRF.From this analysed sample of CRF only two were positive to the observation of amebas what allowed to tint them with Giemsa and also with Lugol, to demonstrate their flagelation capacity and their resistance to TMT in the corresponding test. The citochemical characteristics of the liquids agreed with that outlined in the literature for this organisms,and one of the patients survived, the other one died. The patogenicity of the isolated flagellae-carring amebas was proven in the animal model of Swiss albino mouse and both isolated strains were observed by the electronic microscope. This results are the basis for considering the present report the first one confirming N.Fowleri as aetiologic agent in two cases of PAME in Cuba.


REFERENCES

  1. Schuster FL, Visvesvara GS. Amebae and ciliate protozoo as causal agent of water borne zoonotic disease. Vet. Parasitol. 2004;126(1):91-120.

  2. Oddó BD. Infecciones por amebas de vida libre. Comentarios históricos, taxonomía y nomenclatura, protozoología y cuadros clínicos. Rev. Chi. Infect. 2006;23(3):200-214.

  3. Tolan RW. Amebic meningoencephalitis. Medscape reference. [updated Jan 28 2011]. Disponible en: http://emedicine.medscape.com/article/996227-overview

  4. Vargas-Cepeda J, Gómez-Alcalá AV, Vázquez-Morales JA, Licea-Amaya L, De Jonckheere JF, Lares-Villa F. Succesfull treatment of Naegleria fowleri meningoencephalitis by using intravenous anfothericine B, fluconazole and Rifampicin. Arch. Med Res. Jan-Feb.2005;6(1):83-6.

  5. Siripanths Ch. Anphisoic amoebae: Pathogenic Free-living protozoo.Review of Cases in Thailand. J. Med. Assoc. Thai. 2005;88(5):701-7.

  6. Dos Santos JG. Fatal Primary Amoebic Meningoencefalitis; a retrospective study in Richmond, Virginia. Am.J.Clin.Pathol. 1970;54:737-42.

  7. Culbertson CG. The pathogenicity of soil amoebas. Annu Rev Microbiol. 1971;25:231-54.

  8. Cerva L. Laboratory diagnosis of Primary Amoebic Meningoencephalitis and method for the detection of Limax amoeba in the environment». Folia Parasitol: Prague. 1980;27:1-9.

  9. John DT. Primary Amoebic Meningoencephalitis and the biology of Naegleria fowleri. Ann.Rev.Microbiol. 1982;36:101-23.

  10. De Jonckheere JF, Martinez AJ. Les infections par les Amibes libres. Bull.LInst.Pateur 1981;79:171-205.

  11. Sotolongo F. Meningoencefalitis por amebas de vida libre. Revista 16 de Abril. 1986;(119):8-9.

  12. García Tijera J, Sotolongo F, Cepero F, Ibarra E, García J. Meningoencefalitis amebiana primaria. Estudio de un caso sospechoso y revisión de la literatura médica. Rev Cubana Med Trop. 1978;30:161-6.

  13. Carter KF. Description of a Naegleria sp isolated from two cases of Primary Amoebic Meningoencephalitis, and of the experimental pathological induced by it. J Path. 1970;100(4):219-42.

  14. Bonilla P. Ecología de las amebas patógenas de vida libre en ambientes acuáticos. [consulta 3 Sep 2011]. Disponible en: http://www2.ine.gob.mx/publicaciones/libros/440/cap3.html

  15. Really MF. White KL, Bradley SG. Host resistence of mice to N.fowleri infection. Infect Immun. 1983;42(2):645-52.

  16. Marciano-Cabral F, John DT. Cytopatogenicity of Naegleria fowleri for rat neuroblastoma cell culture: Scaning Electron Microscopic study. Infect.Inmun. 1983;40(3):1214-7.

  17. De Jonckheere JF, Pernin P, Scaglia M, Michel K. A comparative study of 14 strains of Naegleria a highly virulence subspecies: N. australiensis italica. J Protozool. 1984;31(2):324-31.

  18. Kilvington S, Beeching J. Development of a PCR for identification of Naegleria fowleri from the environment. Appl Environ Microbiol. 1995;61(10):3764-7.

  19. Khan A. Naegleria. In: Microbial Pathogenesis. School of Biological and Chemical Sciences, Birkbeck College, University of London. London UK; 2003. p. 227-285.

  20. Griffin J. Parasitic Protozoo. Vol.II. New York: Academia Press;1977.

  21. Hoffman R, Michel R. Distribution of free living amoeba during preparation supply of drinking water. Inst. J. Hyg. Environ. Health, maar vol. 2001;203:215-9.

  22. Darby Ch, Conrado S, Holbrook Th, Chatellier Ch. Primary Amoebic Meningoencephalitis. Am J Dis Child. 1979;133:1025-7.

  23. Bot: Base de Datos del Medicamento. Consejo General de Colegios OficialesFarmacéuticos de España. 7ma Entrega; 2000. Disponible en: http://www.cof.es/bot

  24. Schuster FL, Mendel N. Phenothiazine compounds inhibits in vitro growth of pathogenic free living amoeba. Antimicro agent chemother. 1984;25(1):109-12.

  25. Abad F. Antagonismo entre Itraconazol y Anfotericina B. Prescripción de fármacos. Hosp. Univ. De la Princesa. Univ. Autónoma de Madrid. 1998;4(4).




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Cubana Invest Bioméd. 2011;30